ADN
ADENOSINE
Find entries where: ADN
is present as a standalone ligand in 169 entries
as a non-polymer is covalently linked to polymer or other heterogen groups  5 entries
is present in a polymer sequence 1 entries
Find related ligands:
Chemical Component Summary | |
---|---|
Name | ADENOSINE |
Identifiers | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
Formula | C10 H13 N5 O4 |
Molecular Weight | 267.24 |
Type | NON-POLYMER |
Isomeric SMILES | c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N |
InChI | InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 |
InChIKey | OIRDTQYFTABQOQ-KQYNXXCUSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 32 |
Chiral Atom Count | 4 |
Bond Count | 34 |
Aromatic Bond Count | 9 |
Drug Info: DrugBank
DrugBank ID | DB00640 |
---|---|
Name | Adenosine |
Groups |
|
Description | A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. |
Synonyms |
|
Brand Names |
|
Indication | Used as an initial treatment for the termination of paroxysmal supraventricular tachycardia (PVST), including that associated with accessory bypass tracts, and is a drug of choice for terminating stable, narrow-complex supraventricular tachycardias (SVT). Also used as an adjunct to thallous chloride TI 201 myocardial perfusion scintigraphy (thallium stress test) in patients who are unable to exercise adequately, as well as an adjunct to vagal maneuvers and clinical assessment to establish a specific diagnosis of undefined, stable, narrow-complex SVT. |
Categories |
|
ATC-Code | C01EB10 |
CAS number | 58-61-7 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Adenosine receptor A2a | MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAA... | unknown | agonist |
Adenosine receptor A2b | MLLETQDALYVALELVIAALSVAGNVLVCAAVGTANTLQTPTNYFLVSLA... | unknown | agonist |
Adenosine receptor A3 | MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYF... | unknown | agonist |
Adenosine receptor A1 | MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVS... | unknown | agonist |
Adenosine deaminase | MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVI... | unknown | substrate |
Adenosine kinase | MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSL... | unknown | substrate |
Solute carrier family 28 member 3 | MELRSTAAPRAEGYSNVGFQNEENFLENENTSGNNSIRSRAVQSREHTNT... | unknown | |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
CCDC/CSD | ADENOS10 |
PubChem | 60961 |
ChEBI | CHEBI:16335 |
ChEMBL | CHEMBL477 |
Pharos | CHEMBL477 |